The Cancer Letter

Inside information on cancer research and drug development

Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation

In Brief

Ezra Cohen named chief medical officer of oncology at Tempus
Crystal Rodriguez-Dabney named chief diversity officer and senior VP at Roswell Park
Sudhir Srivastava receives Ruth C. Brufsky Award for Excellence in Clinical Research in Pancreatic Cancer
Mary Daly receives BRCA Impact Award from UPenn Basser Center for BRCA
Paul Goldberg’s Cold War thriller released by FSG
Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

Drugs & Targets

FDA approves Lynparza with abiraterone, prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer
FDA approves Posluma—first radiohybrid PSMA-targeted PET imaging agent for prostate cancer
FDA grants priority review to repotrectinib for locally advanced or metastatic ROS1-positive NSCLC
EMA CHMP recommends approval of Opdivo + chemo for the neoadjuvant treatment of PD-L1 positive, resectable NSCLC at a high risk of recurrence
Lifebit, Flatiron Health partner to accelerate cancer data research
Leal Health establishes proprietary platform for oncologists to obtain personalized clinical trial matches for patients

In The Clinic

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die
Continuous temperature tracking helps manage infection risk after CAR T-cell therapy
Trials & Tribulations
San Antonio Breast Cancer Symposium 2022 tackled big obstacles, recommended solutions for breast cancer progress
Trials & Tribulations
Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment
Does salpingectomy prevent ovarian cancer? Let’s prove it.
Trials & Tribulations

Latest Issue

Read the latest issue
DOWNLOAD THE PDF

UPCOMING EVENTS

There are no upcoming events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?